Comparing the efficacy of Silastic and gloved-Merocel middle meatal spacers for functional endoscopic sinus surgery: a randomized controlled trial

dc.contributor.authorManji, Jamil
dc.contributor.authorHabib, Al-Rahim R.
dc.contributor.authorMacias-Valle, Luis
dc.contributor.authorFinkelstein, Andrés
dc.contributor.authorAlsaleh, Saad
dc.contributor.authorDadgostar, Anali
dc.contributor.authorAl-Asousi, Fahad
dc.contributor.authorOkpaleke, Christopher
dc.contributor.authorJaver, Amin R.
dc.date.accessioned2022-05-20T17:31:57Z
dc.date.available2022-05-20T17:31:57Z
dc.date.issued2018
dc.description.abstractBackground: Spacers are inserted into the middle meatal space (MMS) following functional endoscopic sinus surgery (FESS) to prevent lateralization of the middle turbinate, scarring, and synechiae. Our objective was to determine if the incidence of postoperative synechiae, facial pain/discomfort, pain during spacer removal, scarring, and discharge differed between nasal cavities receiving Silastic or gloved-Merocel (GM) spacers following FESS. Methods: A double-blind, randomized controlled trial (RCT) was conducted in adults requiring bilateral FESS for chronic rhinosinusitis (CRS) ± nasal polyposis. Participants served as their own controls, with each subject receiving both a Silastic and GM spacer. Spacers were inserted into the MMS during FESS and left in situ for 6 days. Participants were reviewed at 6 days, 5 weeks, and 12 weeks postoperatively. The presence of synechiae and scarring were evaluated endoscopically. Inflammation, discharge, and pain during spacer removal were assessed using a visual analogue scale (VAS). Results: Forty-eight participants (96 nasal cavities) were recruited. Preoperatively, Lund-Mackay computed tomography (CT) scores were similar between Silastic-treated and GM-treated cavities (6.38 ± 2.35 vs 6.18 ± 2.17). The incidence of synechiae and scarring did not differ significantly between spacers up to 12 weeks postoperatively. Pain during spacer removal was significantly greater for Silastic than GM spacers (2.13 ± 1.34 vs 1.51 ± 1.23, p = 0.020). Facial pain prior to removal and extent of discharge did not differ significantly between spacers. Conclusion: Following FESS, patients report less pain during removal of GM than Silastic spacers. However, the likelihood of synechiae and scarring did not differ between either of the spacers.es
dc.description.versionVersión Publicadaes
dc.identifier.citationManji J, Habib AR, Macias-Valle L, Finkelstein A, Alsaleh S, Dadgostar A, Al-Asousi F, Okpaleke C, Javer AR. Comparing the efficacy of Silastic and gloved-Merocel middle meatal spacers for functional endoscopic sinus surgery: a randomized controlled trial. Int Forum Allergy Rhinol. 2018 Mar 30. doi: 10.1002/alr.22119. Epub ahead of print. PMID: 29601150.es
dc.identifier.urihttps://doi.org/10.1002/alr.22119es
dc.identifier.urihttp://hdl.handle.net/11447/6115
dc.language.isoenes
dc.subjectFESSes
dc.subjectChronic rhinosinusitises
dc.subjectEndoscopic sinus surgeryes
dc.subjectPostoperativees
dc.subjectQuality of lifees
dc.subjectSinusitises
dc.titleComparing the efficacy of Silastic and gloved-Merocel middle meatal spacers for functional endoscopic sinus surgery: a randomized controlled triales
dc.typeArticlees
dcterms.sourceInternational Forum of Allergy & Rhinologyes

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Int Forum Allergy Rhinol - 2018 - Manji - Comparing the efficacy of Silastic and gloved‐Merocel middle meatal spacers for (1).pdf
Size:
542.75 KB
Format:
Adobe Portable Document Format
Description:
Texto completo
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: